J Transl Med
The Journal of Translational Medicine, with ISSN 1479-5876, is a leading open-access, peer-reviewed journal published by BioMed Central (Springer Nature). It serves as a premier platform for the dissemination of original research, reviews, and commentaries that bridge the critical gap between laboratory discoveries and clinical applications. The journal’s core scope encompasses all facets of translational medicine, including but not limited to biomarker discovery, personalized medicine, gene and cell therapies, immunotherapy, cancer biology, cardiovascular disease, and the development of novel diagnostics and therapeutics. It particularly emphasizes studies that demonstrate the progression of basic scientific findings into preclinical and clinical settings, as well as the reverse translation of clinical observations into mechanistic bench research. The journal publishes a diverse array of article types, including Research Articles, Reviews, Mini-Reviews, Commentaries, Editorials, and Methodology papers, all rigorously peer-reviewed to ensure scientific integrity and clinical relevance. Its target audience is broad and multidisciplinary, comprising basic scientists, clinical researchers, physicians, pharmacologists, and public health professionals dedicated to accelerating the bench-to-bedside continuum. A notable feature is its fully open-access model, ensuring that all published content is freely and permanently available online, which maximizes visibility, citation, and global impact. With a 2026 Impact Factor of 8.4400 and a prestigious JCR Quartile ranking of Q1, the Journal of Translational Medicine stands as a top-tier publication in its field, consistently recognized among the most influential journals for cutting-edge translational research.